Parallel Advisors, LLC Virpax Pharmaceuticals, Inc. Transaction History

Parallel Advisors, LLC

  • $3.87 Billion
  • Q2 2024

A detailed history of Parallel Advisors, LLC transactions in Virpax Pharmaceuticals, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 1 shares of VRPX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024
SELL
$0.27 - $4.95 $3 - $64
-13 Reduced 92.86%
1 $0
Q4 2023

Feb 09, 2024
BUY
$0.24 - $0.82 $3 - $11
14 New
14 $0

Others Institutions Holding VRPX

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Virpax Pharmaceuticals, Inc.

VRPX Quotes by TradingView
  • Ticker VRPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,714,600
  • Market Cap $7.97M
  • Description
  • Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical no...
More about VRPX
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email